Quarterly report [Sections 13 or 15(d)]

STOCKHOLDERS' EQUITY (Details - Stock warrants activity)

v3.25.3
STOCKHOLDERS' EQUITY (Details - Stock warrants activity) - Common Stock Warrants [Member]
 9 Months Ended
Sep. 30, 2025
USD ($)
$ / shares
shares
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]  
Number of shares outstanding, Beginning | shares 14,804
Weighted average exercise price outstanding, Beginning | $ / shares $ 4,158.33
Shares, Granted/purchased | shares 1,848,471
Weighted average exercise price, Granted/purchased | $ / shares $ 12.39
Shares, Exercised | shares (123,603)
Weighted average exercise price, Exercised | $ / shares $ 14.43
Number of shares outstanding, Ending | shares 1,739,672
Weighted average exercise price outstanding, Ending | $ / shares $ 47.54
Weighted average remaining life in years, Outstanding 7 years 2 months 23 days
Intrinsic value, Outstanding | $ $ 32,509
Shares, Exercisable | shares 1,739,672
Weighted average exercise price, Exercisable | $ / shares $ 47.54
Weighted average remaining life in years, Exercisable 7 years 2 months 23 days
Intrinsic value, Exercisable | $ $ 32,509